A clinically validated human saliva metatranscriptomic test for global systems biology studies

The authors report here the development of a high-throughput, automated, inexpensive and clinically validated saliva metatranscriptome test that requires less than 100 μl of saliva. RNA is preserved at the time of sample collection, allowing for ambient-temperature transportation and storage for up...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:BioTechniques. - 1988. - 74(2023), 1 vom: 09. Jan., Seite 31-44
1. Verfasser: Toma, Ryan (VerfasserIn)
Weitere Verfasser: Cai, Ying, Ogundijo, Oyetunji, Hu, Lan, Gline, Stephanie, Demusaj, Diana, Duval, Nathan, Torres, Pedro, Camacho, Francine, Banavar, Guruduth, Vuyisich, Momchilo
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:BioTechniques
Schlagworte:Journal Article clinically validated disease metatranscriptomics microbiome population studies saliva RNA 63231-63-0
LEADER 01000naa a22002652 4500
001 NLM351330860
003 DE-627
005 20231226051115.0
007 cr uuu---uuuuu
008 231226s2023 xx |||||o 00| ||eng c
024 7 |a 10.2144/btn-2022-0104  |2 doi 
028 5 2 |a pubmed24n1171.xml 
035 |a (DE-627)NLM351330860 
035 |a (NLM)36622006 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Toma, Ryan  |e verfasserin  |4 aut 
245 1 2 |a A clinically validated human saliva metatranscriptomic test for global systems biology studies 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 30.01.2023 
500 |a Date Revised 14.02.2023 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a The authors report here the development of a high-throughput, automated, inexpensive and clinically validated saliva metatranscriptome test that requires less than 100 μl of saliva. RNA is preserved at the time of sample collection, allowing for ambient-temperature transportation and storage for up to 28 days. Critically, the RNA preservative is also able to inactivate pathogenic microorganisms, rendering the samples noninfectious and allowing for safe and easy shipping. Given the unique set of convenience, low cost, safety and technical performance, this saliva metatranscriptomic test can be integrated into longitudinal, global-scale systems biology studies that will lead to an accelerated development of precision medicine, diagnostic and therapeutic tools 
650 4 |a Journal Article 
650 4 |a clinically validated 
650 4 |a disease 
650 4 |a metatranscriptomics 
650 4 |a microbiome 
650 4 |a population studies 
650 4 |a saliva 
650 7 |a RNA  |2 NLM 
650 7 |a 63231-63-0  |2 NLM 
700 1 |a Cai, Ying  |e verfasserin  |4 aut 
700 1 |a Ogundijo, Oyetunji  |e verfasserin  |4 aut 
700 1 |a Hu, Lan  |e verfasserin  |4 aut 
700 1 |a Gline, Stephanie  |e verfasserin  |4 aut 
700 1 |a Demusaj, Diana  |e verfasserin  |4 aut 
700 1 |a Duval, Nathan  |e verfasserin  |4 aut 
700 1 |a Torres, Pedro  |e verfasserin  |4 aut 
700 1 |a Camacho, Francine  |e verfasserin  |4 aut 
700 1 |a Banavar, Guruduth  |e verfasserin  |4 aut 
700 1 |a Vuyisich, Momchilo  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t BioTechniques  |d 1988  |g 74(2023), 1 vom: 09. Jan., Seite 31-44  |w (DE-627)NLM012627046  |x 1940-9818  |7 nnns 
773 1 8 |g volume:74  |g year:2023  |g number:1  |g day:09  |g month:01  |g pages:31-44 
856 4 0 |u http://dx.doi.org/10.2144/btn-2022-0104  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_22 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_60 
912 |a GBV_ILN_62 
912 |a GBV_ILN_65 
912 |a GBV_ILN_70 
912 |a GBV_ILN_99 
912 |a GBV_ILN_121 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_350 
912 |a GBV_ILN_618 
912 |a GBV_ILN_640 
912 |a GBV_ILN_754 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2002 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2007 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2009 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2015 
912 |a GBV_ILN_2018 
912 |a GBV_ILN_2023 
912 |a GBV_ILN_2035 
912 |a GBV_ILN_2040 
912 |a GBV_ILN_2060 
912 |a GBV_ILN_2099 
912 |a GBV_ILN_2105 
912 |a GBV_ILN_2121 
912 |a GBV_ILN_2470 
951 |a AR 
952 |d 74  |j 2023  |e 1  |b 09  |c 01  |h 31-44